159 related articles for article (PubMed ID: 8105264)
1. Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning.
Takahashi H; Snow BJ; Bhatt MH; Peppard R; Eisen A; Calne DB
Lancet; 1993 Oct; 342(8878):1016-8. PubMed ID: 8105264
[TBL] [Abstract][Full Text] [Related]
2. [Presynaptic nigrostriatal function in Parkinson disease and Parkinson-plus syndromes. Comparative studies using positron emission tomography with L-6-(18F)fluorodopa].
Cordes M; Poewe W
Nervenarzt; 1994 Oct; 65(10):696-9. PubMed ID: 7808568
[TBL] [Abstract][Full Text] [Related]
3. The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomography.
Snow BJ; Bhatt M; Martin WR; Li D; Calne DB
J Neurol Neurosurg Psychiatry; 1991 Jan; 54(1):12-7. PubMed ID: 1901347
[TBL] [Abstract][Full Text] [Related]
4. Nigrostriatal dysfunction in patients with amyotrophic lateral sclerosis and parkinsonism.
Park HK; Lim YM; Kim JS; Lee MC; Kim SM; Kim BJ; Kim KK
J Neurol Sci; 2011 Feb; 301(1-2):12-3. PubMed ID: 21167502
[TBL] [Abstract][Full Text] [Related]
5. Age-dependent decline of nigrostriatal dopaminergic function: a positron emission tomographic study of grandparents and their grandchildren.
Cordes M; Snow BJ; Cooper S; Schulzer M; Pate BD; Ruth TJ; Calne DB
Ann Neurol; 1994 Oct; 36(4):667-70. PubMed ID: 7944302
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic dysfunction in midbrain dystonia: anatomoclinical study using 3-dimensional magnetic resonance imaging and fluorodopa F 18 positron emission tomography.
Vidailhet M; Dupel C; Lehéricy S; Remy P; Dormont D; Serdaru M; Jedynak P; Veber H; Samson Y; Marsault C; Agid Y
Arch Neurol; 1999 Aug; 56(8):982-9. PubMed ID: 10448804
[TBL] [Abstract][Full Text] [Related]
7. The role of radiotracer imaging in Parkinson disease.
Ravina B; Eidelberg D; Ahlskog JE; Albin RL; Brooks DJ; Carbon M; Dhawan V; Feigin A; Fahn S; Guttman M; Gwinn-Hardy K; McFarland H; Innis R; Katz RG; Kieburtz K; Kish SJ; Lange N; Langston JW; Marek K; Morin L; Moy C; Murphy D; Oertel WH; Oliver G; Palesch Y; Powers W; Seibyl J; Sethi KD; Shults CW; Sheehy P; Stoessl AJ; Holloway R
Neurology; 2005 Jan; 64(2):208-15. PubMed ID: 15668415
[TBL] [Abstract][Full Text] [Related]
8. Nigrostriatal function in humans studied with positron emission tomography.
Martin WR; Palmer MR; Patlak CS; Calne DB
Ann Neurol; 1989 Oct; 26(4):535-42. PubMed ID: 2510586
[TBL] [Abstract][Full Text] [Related]
9. Young-onset Parkinson disease with and without parkin gene mutations: a fluorodopa F 18 positron emission tomography study.
Thobois S; Ribeiro MJ; Lohmann E; Dürr A; Pollak P; Rascol O; Guillouet S; Chapoy E; Costes N; Agid Y; Remy P; Brice A; Broussolle E;
Arch Neurol; 2003 May; 60(5):713-8. PubMed ID: 12756135
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomographic scanning demonstrates a presynaptic dopaminergic lesion in Lytico-Bodig. The amyotrophic lateral sclerosis-parkinsonism-dementia complex of Guam.
Snow BJ; Peppard RF; Guttman M; Okada J; Martin WR; Steele J; Eisen A; Carr G; Schoenberg B; Calne D
Arch Neurol; 1990 Aug; 47(8):870-4. PubMed ID: 2375693
[TBL] [Abstract][Full Text] [Related]
11. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?
Pirker W
Mov Disord; 2003 Oct; 18 Suppl 7():S43-51. PubMed ID: 14531046
[TBL] [Abstract][Full Text] [Related]
12. Nigrofrontal dopaminergic function as assessed by 18F-dopa PET.
Otsuka M; Ichiya Y; Kuwabara Y; Sasaki M; Yoshida T; Fukumura T; Masuda K
Nucl Med Commun; 1995 Dec; 16(12):1021-5. PubMed ID: 8719983
[TBL] [Abstract][Full Text] [Related]
13. A positron emission tomography study on the role of nigral lesions in parkinsonism in patients with amyotrophic lateral sclerosis.
Hideyama T; Momose T; Shimizu J; Tsuji S; Kwak S
Arch Neurol; 2006 Dec; 63(12):1719-22. PubMed ID: 17172610
[TBL] [Abstract][Full Text] [Related]
14. Nigrostriatal dopaminergic function in familial amyotrophic lateral sclerosis patients with and without copper/zinc superoxide dismutase mutations.
Przedborski S; Dhawan V; Donaldson DM; Murphy PL; McKenna-Yasek D; Mandel FS; Brown RH; Eidelberg D
Neurology; 1996 Dec; 47(6):1546-51. PubMed ID: 8960743
[TBL] [Abstract][Full Text] [Related]
15. High levels of dopamine activity in the basal ganglia of cigarette smokers.
Salokangas RK; Vilkman H; Ilonen T; Taiminen T; Bergman J; Haaparanta M; Solin O; Alanen A; Syvälahti E; Hietala J
Am J Psychiatry; 2000 Apr; 157(4):632-4. PubMed ID: 10739427
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions.
Vingerhoets FJ; Snow BJ; Tetrud JW; Langston JW; Schulzer M; Calne DB
Ann Neurol; 1994 Nov; 36(5):765-70. PubMed ID: 7979223
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic deficit in amyotrophic lateral sclerosis assessed with [I-123] IPT single photon emission computed tomography.
Borasio GD; Linke R; Schwarz J; Schlamp V; Abel A; Mozley PD; Tatsch K
J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):263-5. PubMed ID: 9703186
[TBL] [Abstract][Full Text] [Related]
18. Reproducibility of fluorine-18-6-fluorodopa positron emission tomography in normal human subjects.
Vingerhoets FJ; Snow BJ; Schulzer M; Morrison S; Ruth TJ; Holden JE; Cooper S; Calne DB
J Nucl Med; 1994 Jan; 35(1):18-24. PubMed ID: 8285951
[TBL] [Abstract][Full Text] [Related]
19. Nigrostriatal function in vitamin E deficiency: clinical, experimental, and positron emission tomographic studies.
Dexter DT; Brooks DJ; Harding AE; Burn DJ; Muller DP; Goss-Sampson MA; Jenner PG; Marsden CD
Ann Neurol; 1994 Mar; 35(3):298-303. PubMed ID: 8122882
[TBL] [Abstract][Full Text] [Related]
20. Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels.
Snow BJ; Tooyama I; McGeer EG; Yamada T; Calne DB; Takahashi H; Kimura H
Ann Neurol; 1993 Sep; 34(3):324-30. PubMed ID: 8363349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
